Nobel prize honors scientists who pioneered light-activated gene therapy technology

Three researchers received this year’s Nobel Prize in medicine for creating optogenetics, a technique that uses light to steer nerve activity. The award recognizes their foundational work that has largely been applied in laboratory studies.

While optogenetics has been a powerful research tool, it also opens the door to light-activated gene therapies that could allow precise control of cellular processes in patients. Scientists see the approach as a way to target treatments with high spatial and temporal accuracy.

The prize highlights the growing interest in translating optogenetic methods into clinical applications, signalling new opportunities for biotech development and investment in the field.